TY - JOUR
T1 - Potential non-hypoxic/ischemic causes of increased cerebral interstitial fluid lactate/pyruvate ratio
T2 - A review of available literature
AU - Larach, Daniel B.
AU - Kofke, W. Andrew
AU - Le Roux, Peter
N1 - Funding Information:
Acknowledgments The authors gratefully acknowledge the helpful and insightful suggestions of Julien F. Biebuyck, David F. Wilson, Gretchen L. Redline, Marilyn G. Larach, and Sarah M. Gibbs in the preparation of the manuscript. DBL received financial support from the Clinical Neurosciences Training Program (CNST) Summer Research Fellowship program of the University of Pennsylvania School of Medicine.
Funding Information:
Disclosure PLR has received support and research funding from Integra LifeSciences (Plainsboro, NJ) and CMA Microdialysis (Solna, Sweden). WAK has received support and research funding from Covidien (Mansfield, MA) and the U.S. Public Health Service.
PY - 2011/12
Y1 - 2011/12
N2 - Microdialysis, an in vivo technique that permits collection and analysis of small molecular weight substances from the interstitial space, was developed more than 30 years ago and introduced into the clinical neurosciences in the 1990s. Today cerebral microdialysis is an established, commercially available clinical tool that is focused primarily on markers of cerebral energy metabolism (glucose, lactate, and pyruvate) and cell damage (glycerol), and neurotransmitters (glutamate). Although the brain comprises only 2% of body weight, it consumes 20% of total body energy. Consequently, the ability to monitor cerebral metabolism can provide significant insights during clinical care. Measurements of lactate, pyruvate, and glucose give information about the comparative contributions of aerobic and anaerobic metabolisms to brain energy. The lactate/pyruvate ratio reflects cytoplasmic redox state and thus provides information about tissue oxygenation. An elevated lactate pyruvate ratio (>40) frequently is interpreted as a sign of cerebral hypoxia or ischemia. However, several other factors may contribute to an elevated LPR. This article reviews potential non-hypoxic/ischemic causes of an increased LPR.
AB - Microdialysis, an in vivo technique that permits collection and analysis of small molecular weight substances from the interstitial space, was developed more than 30 years ago and introduced into the clinical neurosciences in the 1990s. Today cerebral microdialysis is an established, commercially available clinical tool that is focused primarily on markers of cerebral energy metabolism (glucose, lactate, and pyruvate) and cell damage (glycerol), and neurotransmitters (glutamate). Although the brain comprises only 2% of body weight, it consumes 20% of total body energy. Consequently, the ability to monitor cerebral metabolism can provide significant insights during clinical care. Measurements of lactate, pyruvate, and glucose give information about the comparative contributions of aerobic and anaerobic metabolisms to brain energy. The lactate/pyruvate ratio reflects cytoplasmic redox state and thus provides information about tissue oxygenation. An elevated lactate pyruvate ratio (>40) frequently is interpreted as a sign of cerebral hypoxia or ischemia. However, several other factors may contribute to an elevated LPR. This article reviews potential non-hypoxic/ischemic causes of an increased LPR.
UR - http://www.scopus.com/inward/record.url?scp=84856259120&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84856259120&partnerID=8YFLogxK
U2 - 10.1007/s12028-011-9517-8
DO - 10.1007/s12028-011-9517-8
M3 - Review article
C2 - 21336786
AN - SCOPUS:84856259120
SN - 1541-6933
VL - 15
SP - 609
EP - 622
JO - Neurocritical Care
JF - Neurocritical Care
IS - 3
ER -